Pediatric Headache

Continuum (Minneapolis, Minn.)
|August 8, 2015
PubMed

Insights

Childhood headaches are common but underrecognized. A standardized approach to evaluation and multidisciplinary treatment plans are crucial for improving outcomes in pediatric headache patients.

Area of Science:

  • Pediatric Neurology
  • Child and Adolescent Health
  • Headache Medicine

Background:

  • Headaches are a prevalent health concern in children and adolescents.
  • Underrecognition of headaches as a disease in this demographic is a significant issue.
  • Unique characteristics of childhood headaches contribute to diagnostic challenges.

Purpose of the Study:

  • To highlight unique aspects of evaluating headaches in children and adolescents.
  • To discuss the impact of headaches on pediatric daily functioning.
  • To outline a comprehensive treatment strategy for pediatric headaches.

Main Methods:

  • Review of current literature on childhood headaches.
  • Analysis of factors contributing to underrecognition.
  • Synthesis of approaches for evaluation and management.

Main Results:

  • Standardized evaluation improves diagnosis and management of pediatric headaches.
  • Multidisciplinary treatment plans, informed by pediatric and adult studies, are beneficial.
  • Addressing functional impact, disability, and comorbidities is key.

Conclusions:

  • A structured approach to pediatric headache evaluation is essential.
  • Comprehensive management includes acute, preventive, and biobehavioral strategies.
  • Improving recognition and management can enhance overall outcomes for children with headaches.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
378
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
341
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
804
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
484
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
762
Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
1.3K